Nucor earnings beat by $0.08, revenue fell short of estimates
SUNNYVALE, CA—On June 2, 2025, Ghazi Sassine, the President and CEO of Synopsys Inc . (NASDAQ:SNPS), a $72.35 billion market cap software company trading near its Fair Value according to InvestingPro, executed a series of stock transactions, as reported in an SEC filing. Sassine sold 11,366 shares of Synopsys common stock, generating approximately $5.2 million. The shares were sold at a weighted average price of $457.93, with individual transaction prices ranging from $452.23 to $461.18. The transaction comes as the stock has experienced an 8.92% decline over the past week, though the company maintains impressive gross profit margins of 81.4%.
In addition to the sales, Sassine exercised stock options to acquire 11,366 shares at a price of $89.76 per share, a transaction valued at approximately $1.02 million. This exercise was conducted under a Rule 10b5-1 trading plan adopted on September 30, 2024.
Following these transactions, Sassine’s direct ownership in Synopsys stands at 71,589 shares.
In other recent news, Synopsys, Inc. announced the suspension of its financial guidance for the third quarter and full fiscal year of 2025. This decision follows a letter from the U.S. Department of Commerce’s Bureau of Industry and Security detailing new export restrictions concerning China. Before this announcement, Synopsys had projected third-quarter revenue between $1.755 billion and $1.785 billion and full-year revenue between $6.745 billion and $6.805 billion. The company recently reported second-quarter earnings per share of $3.67, surpassing analyst expectations of $3.39, with revenue reaching $1.604 billion.
Analysts from Stifel and KeyBanc have maintained positive ratings for Synopsys, with price targets of $550 and $575, respectively. Stifel analysts noted the company’s strong backlog growth, while KeyBanc highlighted potential growth in regions outside China. BofA Securities also increased its price target for Synopsys to $575, maintaining a Buy rating and noting a decline in China sales but resilience in other markets. Synopsys plans to finalize its acquisition of Ansys (NASDAQ:ANSS) by mid-2025, with approvals pending in China. Despite challenges, Synopsys aims for approximately 11% growth in fiscal year 2025, reflecting confidence in its long-term prospects.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.